Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 111

1.

[Pseudo-tumor lesions induced by infectious agents. Case No. 4].

Ilié M, Benzaquen J, Diascorn Y, Cohen C.

Ann Pathol. 2019 May 16. pii: S0242-6498(19)30070-7. doi: 10.1016/j.annpat.2019.04.001. [Epub ahead of print] French. No abstract available.

PMID:
31104854
2.

[Pseudo tumor lesions induced by infectious agents. Case no. 3].

Ilié M, Benzaquen J, Diascorn Y, Cohen C.

Ann Pathol. 2019 Apr 19. pii: S0242-6498(19)30049-5. doi: 10.1016/j.annpat.2019.03.002. [Epub ahead of print] French. No abstract available.

PMID:
31010595
3.

Multicenter evaluation of a novel ROS1 immunohistochemistry assay (SP384) for detection of ROS1 rearrangements in a large cohort of lung adenocarcinoma patients.

Hofman V, Rouquette I, Long-Mira E, Piton N, Chamorey E, Heeke S, Vignaud JM, Yguel C, Mazières J, Lepage AL, Bibeau F, Begueret H, Lassalle S, Lalvée S, Zahaf K, Benzaquen J, Poudenx M, Marquette CH, Sabourin JC, Ilié M, Hofman P.

J Thorac Oncol. 2019 Apr 15. pii: S1556-0864(19)30283-7. doi: 10.1016/j.jtho.2019.03.024. [Epub ahead of print]

PMID:
30999109
4.

[Recent updates regarding PD-L1 testing in non-small cell lung carcinoma].

Adam J, Forest F, Mansuet-Lupo A, Ilié M; pour le groupe PATTERN (PAThologistes Thoraciques de valorisation de l'Expertise, de la Recherche et de l'iNnovation Fondation Synergie Lyon Cancer).

Ann Pathol. 2019 Mar 7. pii: S0242-6498(19)30034-3. doi: 10.1016/j.annpat.2019.01.018. [Epub ahead of print] French. No abstract available.

PMID:
30853496
5.

Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer-Just About Ready for Prime-Time?

Hofman P, Badoual C, Henderson F, Berland L, Hamila M, Long-Mira E, Lassalle S, Roussel H, Hofman V, Tartour E, Ilié M.

Cancers (Basel). 2019 Feb 27;11(3). pii: E283. doi: 10.3390/cancers11030283. Review.

6.

Circulating Tumor Cell Detection in Lung Cancer: But to What End?

Hofman V, Heeke S, Marquette CH, Ilié M, Hofman P.

Cancers (Basel). 2019 Feb 23;11(2). pii: E262. doi: 10.3390/cancers11020262. Review.

7.

The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back Again.

Hofman P, Ayache N, Barbry P, Barlaud M, Bel A, Blancou P, Checler F, Chevillard S, Cristofari G, Demory M, Esnault V, Falandry C, Gilson E, Guérin O, Glaichenhaus N, Guigay J, Ilié M, Mari B, Marquette CH, Paquis-Flucklinger V, Prate F, Saintigny P, Seitz-Polsky B, Skhiri T, Van Obberghen-Schilling E, Van Obberghen E, Yvan-Charvet L.

Cancers (Basel). 2019 Feb 21;11(2). pii: E250. doi: 10.3390/cancers11020250.

8.

Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors.

Berland L, Heeke S, Humbert O, Macocco A, Long-Mira E, Lassalle S, Lespinet-Fabre V, Lalvée S, Bordone O, Cohen C, Leroy S, Hofman V, Hofman P, Ilié M.

J Thorac Dis. 2019 Jan;11(Suppl 1):S71-S80. doi: 10.21037/jtd.2018.11.102. Review.

9.

[The age of artificial intelligence in lung cancer pathology: Between hope, gloom and perspectives].

Heeke S, Delingette H, Fanjat Y, Long-Mira E, Lassalle S, Hofman V, Benzaquen J, Marquette CH, Hofman P, Ilié M.

Ann Pathol. 2019 Apr;39(2):130-136. doi: 10.1016/j.annpat.2019.01.003. Epub 2019 Feb 13. French.

PMID:
30772062
10.

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients.

Long-Mira E, Ilie M, Chamorey E, Leduff-Blanc F, Montaudié H, Tanga V, Allégra M, Lespinet-Fabre V, Bordone O, Bonnetaud C, Schiappa R, Butori C, Bence C, Lacour JP, Hofman V, Hofman P.

Oncotarget. 2018 Nov 16;9(90):36238-36249. doi: 10.18632/oncotarget.26343. eCollection 2018 Nov 16.

11.

Spotlight on tumor mutational burden in patients with non-small cell lung carcinoma.

Ilie M, Hofman P.

Transl Lung Cancer Res. 2018 Dec;7(6):614-615. doi: 10.21037/tlcr.2018.08.06. No abstract available.

12.

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients.

Ilié M, Ngo-Mai M, Long-Mira E, Lassalle S, Butori C, Bence C, Hamila M, Hofman V, Hofman P.

J Vis Exp. 2018 Sep 25;(139). doi: 10.3791/58082.

PMID:
30320751
13.

Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.

Fumet JD, Richard C, Ledys F, Klopfenstein Q, Joubert P, Routy B, Truntzer C, Gagné A, Hamel MA, Guimaraes CF, Coudert B, Arnould L, Favier L, Lagrange A, Ladoire S, Saintigny P, Ortiz-Cuaran S, Perol M, Foucher P, Hofman P, Ilie M, Chevrier S, Boidot R, Derangere V, Ghiringhelli F.

Br J Cancer. 2018 Oct;119(8):950-960. doi: 10.1038/s41416-018-0220-9. Epub 2018 Oct 15.

PMID:
30318514
14.

Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancer.

Ilie M, Beaulande M, Hamila M, Erb G, Hofman V, Hofman P.

Lung Cancer. 2018 Oct;124:90-94. doi: 10.1016/j.lungcan.2018.07.037. Epub 2018 Jul 31.

PMID:
30268486
15.

ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question-to treat or not to treat?

Cabillic F, Hofman P, Ilie M, Peled N, Hochmair M, Dietel M, Von Laffert M, Gosney JR, Lopez-Rios F, Erb G, Schalles U, Barlesi F.

ESMO Open. 2018 Sep 17;3(6):e000419. doi: 10.1136/esmoopen-2018-000419. eCollection 2018.

16.

Dermoscopy of eccrine angiomatous hamartoma: The spitzoid pattern.

Kelati A, Chiaverini C, Giacchero D, Ilie M, Lacour JP, Bahadoran P.

JAAD Case Rep. 2018 Sep 18;4(8):835-836. doi: 10.1016/j.jdcr.2018.06.026. eCollection 2018 Sep. No abstract available.

17.

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma.

Ilié M, Beaulande M, Ben Hadj S, Chamorey E, Schiappa R, Long-Mira E, Lassalle S, Butori C, Cohen C, Leroy S, Guérin O, Mouroux J, Marquette CH, Pomerol JF, Erb G, Hofman V, Hofman P.

Cancers (Basel). 2018 Sep 13;10(9). pii: E326. doi: 10.3390/cancers10090326.

18.

Matrix Stiffening and EGFR Cooperate to Promote the Collective Invasion of Cancer Cells.

Grasset EM, Bertero T, Bozec A, Friard J, Bourget I, Pisano S, Lecacheur M, Maiel M, Bailleux C, Emelyanov A, Ilie M, Hofman P, Meneguzzi G, Duranton C, Bulavin DV, Gaggioli C.

Cancer Res. 2018 Sep 15;78(18):5229-5242. doi: 10.1158/0008-5472.CAN-18-0601. Epub 2018 Jul 19.

PMID:
30026329
19.

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?

Washetine K, Heeke S, Bonnetaud C, Kara-Borni M, Ilié M, Lassalle S, Butori C, Long-Mira E, Marquette CH, Cohen C, Mouroux J, Selva E, Tanga V, Bence C, Félix JM, Gazoppi L, Skhiri T, Gormally E, Boucher P, Clément B, Dagher G, Hofman V, Hofman P.

Cancers (Basel). 2018 Jun 29;10(7). pii: E220. doi: 10.3390/cancers10070220.

20.

[Carcinoma of unknown primary. Case no. 7].

Ilié M.

Ann Pathol. 2018 Jun;38(3):191-193. doi: 10.1016/j.annpat.2018.04.016. Epub 2018 Jun 19. Review. French. No abstract available.

PMID:
29929748

Supplemental Content

Loading ...
Support Center